Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinya Otsuka

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2022
Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in JapanShinya Otsuka, Kei Hiraoka, Masato Suzuoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[A case of resection of synchronous multiple liver metastases from colorectal cancer after FOLFOX chemotherapy]Shinya Otsuka, Masaru Inagaki, Manabu Nishie, et al.
Annals of Surgical Treatment and Research|August 26, 2022
Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgeryMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Digestive Surgery|July 22, 2024
Albumin-Lymphocyte-Globulin-C-Reactive Protein Index as a Novel Prognostic Biomarker for Hepatocellular Carcinoma after HepatectomyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Journal of Gastrointestinal Cancer|February 25, 2024
Prognostic Significance of Sarcopenia and Systemic Inflammatory Markers in Biliary Tract Cancer: A Retrospective Cohort StudyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Asian Journal of Surgery|February 22, 2024
Predictive values of sarcopenia and systemic inflammation-based markers in advanced hepatocellular carcinoma after hepatectomyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Medicine|June 2, 2023
Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: A systematic review and meta-analysisMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of pathological complete response of metachronous multiple liver metastases from colorectal cancer after mFOLFOX+bevacizumab chemotherapy]Shinya Otsuka, Masaru Inagaki, Manabu Nishie, et al.
Surgery Today|July 6, 2026
Validation of a nomogram with inflammation-based markers developed to predict difficult laparoscopic cholecystectomy in patients with acute cholecystitisMasashi Utsumi, Masaru Inagaki, Ryusei Takahashi, et al.
Radiation Oncology (London, England)|September 21, 2010
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor sizeFumiya Baba, Yuta Shibamoto, Hiroyuki Ogino, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 12, 2022
Antibody responses induced by the BNT162b2 mRNA COVID-19 vaccine in healthcare workers in a single community hospital in JapanShinya Otsuka, Kei Hiraoka, Masato Suzuoki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 20, 2009
[A case of resection of synchronous multiple liver metastases from colorectal cancer after FOLFOX chemotherapy]Shinya Otsuka, Masaru Inagaki, Manabu Nishie, et al.
Annals of Surgical Treatment and Research|August 26, 2022
Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgeryMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Digestive Surgery|July 22, 2024
Albumin-Lymphocyte-Globulin-C-Reactive Protein Index as a Novel Prognostic Biomarker for Hepatocellular Carcinoma after HepatectomyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Journal of Gastrointestinal Cancer|February 25, 2024
Prognostic Significance of Sarcopenia and Systemic Inflammatory Markers in Biliary Tract Cancer: A Retrospective Cohort StudyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Asian Journal of Surgery|February 22, 2024
Predictive values of sarcopenia and systemic inflammation-based markers in advanced hepatocellular carcinoma after hepatectomyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Medicine|June 2, 2023
Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: A systematic review and meta-analysisMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 29, 2009
[A case of pathological complete response of metachronous multiple liver metastases from colorectal cancer after mFOLFOX+bevacizumab chemotherapy]Shinya Otsuka, Masaru Inagaki, Manabu Nishie, et al.
Surgery Today|July 6, 2026
Validation of a nomogram with inflammation-based markers developed to predict difficult laparoscopic cholecystectomy in patients with acute cholecystitisMasashi Utsumi, Masaru Inagaki, Ryusei Takahashi, et al.
Radiation Oncology (London, England)|September 21, 2010
Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor sizeFumiya Baba, Yuta Shibamoto, Hiroyuki Ogino, et al.
Pageof 11